DKL insider plans sale of 250 common shares

A holder associated with DKL has filed a Form 144 notice to sell 250 shares of common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of 13095.00, on or about 02/04/2026.

Accepted by SEC EDGAR 02/04/2026 - 10:05 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

A holder associated with DKL has filed a Form 144 notice to sell 250 shares of common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value of 13095.00, on or about 02/04/2026. These 250 shares were acquired on 03/10/2023 via restricted stock vesting from the issuer as compensation. The notice also lists prior sales over the past three months by the same seller of 250 shares each month, with gross proceeds of 11250.00, 11465.00, and 11747.50, respectively.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the DKL Form 144 filing disclose about upcoming share sales?

The Form 144 shows a DKL holder intends to sell 250 common shares on the NYSE. The planned sale, through Fidelity Brokerage Services, has an aggregate market value of $13,095.00 and is expected around February 4, 2026, subject to market and regulatory conditions.

How many DKL shares has the insider recently sold under this Form 144?

The filing lists prior sales of 250 DKL common shares in each of the last three months. Gross proceeds were $11,250.00 in November 2025, $11,465.00 in December 2025, and $11,747.50 in January 2026, all by the same named seller.

How were the DKL shares in the new Form 144 acquired?

The 250 DKL common shares covered by this Form 144 were acquired on March 10, 2023. They came from restricted stock vesting granted by the issuer as compensation, rather than an open-market cash purchase, according to the acquisition information in the filing.

Which broker and exchange are involved in the planned DKL share sale?

The Form 144 identifies Fidelity Brokerage Services LLC as the broker handling the DKL sale. The 250 common shares are planned to be sold on the NYSE, providing a listed, public market venue for executing the transaction at prevailing market prices.

What is the outstanding DKL share count referenced in the Form 144?

The notice states that 53,480,401 DKL common shares were outstanding. This outstanding share figure provides context for the relative size of the planned 250-share sale described in the filing but does not indicate any new issuance of additional shares.

Who is named as the seller in the recent DKL Form 144 history?

The filing lists Reuven Spiegel, with a Brentwood, Tennessee address, as the seller for the past three months. Each month’s entry shows sales of 250 DKL common shares and reports the respective gross proceeds for November 2025, December 2025, and January 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001615515
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Delek Logistics Partners, LP
SEC File Number	001-35721
Address of Issuer	310 SEVEN SPRINGS WAY SUITE 500 BRENTWOOD TENNESSEE 37027
Phone	6157716701
Name of Person for Whose Account the Securities are To Be Sold	Spiegel Reuven
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	250	13095.00	53480401	02/04/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/10/2023	Restricted Stock Vesting	Issuer			250	03/10/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Reuven Spiegel 310 Seven Springs Way Suite 500 Brentwood TN 37027	Common	11/05/2025	250	11250.00
Reuven Spiegel 310 Seven Springs Way Suite 500 Brentwood TN 37027	Common	12/04/2025	250	11465.00
Reuven Spiegel 310 Seven Springs Way Suite 500 Brentwood TN 37027	Common	01/05/2026	250	11747.50

144: Remarks and Signature

Remarks
Date of Notice	02/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/06/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Reuven Spiegel
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)